Mesothelioma Cancer Centers
Originally named “Presbyterian Hospital of Philadelphia,” Penn Presbyterian Medical Center was founded in 1871 by a religious group known as the Alliance of Philadelphia Presbyteries. The hospital was small to start: a 45-bed facility situated on a 2.5-acre plot of land. Throughout the century that followed, however, Penn Presbyterian would evolve into its current 300-bed, 16-acre campus. In 1995, the hospital, which was then known as “Presbyterian Medical Center”, became affiliated with the University of Pennsylvania and has since changed its name to Penn Presbyterian Medical Center.
Penn Presbyterian has a strong nursing history; its Presbyterian’s School of Nursing opened its doors very early, in 1887. As a result, Presbyterian continues to place a strong emphasis on the valuable role nurses play in the treatment and healing process.
The hospital is also known for other significant medical accomplishments; for example, Penn Presbyterian created the region’s first outpatient pulmonary care facility. The Philadelphia Heart Institute continues to provide cutting-edge care as part of the university. Several other university medical programs, including programs in cardiology, family medicine, psychiatry, radiology and surgery, are located on Penn Presbyterian’s campus, offering convenience for patients and ensuring that the university’s top doctors and researchers are closely tied to Penn Presbyterian.
Penn Presbyterian is affiliated with the Abramson Cancer Center, offering patients quality, comprehensive care. Mesothelioma patients are treated through Penn Presbyterian's Mesothelioma and Pleural Program. There, a multidisciplinary team of experts work together to provide patients with specialized care and a variety of treatments. Pleural mesothelioma patients have the option to pursue treatment at their Harron Lung Center, where there are experts in treating lung disease.
The main goal of The Mesothelioma and Pleural Program is, "to provide you with comprehensive and compassionate care at the highest level possible, both now and in the future." The program strives off of not just harnessing its expertise to treat patients, but also its compassion. When receiving treatment here, the patient's medical team will meet weekly to discuss their case in great depth, ensuring that they are on the right treatment path. A patient navigator is also provided to each individual, helping them with any questions they might have, appointment scheduling and more.
For mesothelioma patients wishing to undergo experimental treatments, it is possible at Penn Presbyterian. If eligible, there are a variety of clinical trials through Penn Medicine that patients may be able to try.
- Pleural disease
- Clinical trials and experimental treatments
- Beacon Award for Excellence
- Magnet Recognized
- Ranked #1 in the region and a top hospital the nation by U.S. News & World Report
- Ranking doctors in Philadelphia Magazine's Top Doctors
- Truven Health Analytics Top 100 Hopsitals ranking
Mesothelioma Clinical Trials at Penn Presbyterian Medical Center
The following clinical trials are in progress or actively recruiting participants at Penn Presbyterian Medical Center:
Conditions: Advanced Cancer; Metastatic Cancer; Non-Hodgkin's Lymphoma; Metastatic Breast Cancer; Malignant Mesothelioma; Non-small Cell Lung Cancer Last Updated: June 5, 2019 Status: Active, not recruiting
Conditions: Mesothelioma; Bladder Cancer; Melanoma; Squamous Cell Carcinoma of the Head and Neck; Non Small Cell Lung Cancer; Clear Cell Renal Cell Carcinoma; Ovarian Cancer; Thyroid Cancer; Breast Cancer; Pancreatic Cancer; Prostate Cancer; Colon Cancer; Soft Tissue Sarcoma Last Updated: March 5, 2019 Status: Recruiting
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette